Plasma levels of plasminogen activator inhibitor type 1, factor VIII, prothrombin activation fragment 1+2, anticardiolipin, and antiprothrombin antibodies are risk factors for thrombosis in hemodialysis patients

Seminars in Nephrology

Volumn 24, Issue 5, 2004, Pages 495-501

  Molino, Daniela ^a,b   De Santo, Natale G ^a   Marotta, Rosa ^a,b   Anastasio, Pietro ^a   Mosavat, Mahrokh ^b   De Lucia, Domenico ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Lab Hemostasis Thromb Second U

Author keywords

activation fragment 1+2; anticardiolipin antibodies; antiprothrombin antibodies; bleeding; coagulation; factor VIII; fistula dysfunction; hemodialysis; hypofibrinolysis; prothrombin; thrombosis

Indexed keywords

ANTITHROMBIN III; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8A; CARDIOLIPIN ANTIBODY; FIBRINOGEN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN S; PROTHROMBIN; PROTHROMBIN ANTIBODY; TISSUE FACTOR PATHWAY INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ANTIBODY BLOOD LEVEL; BLOOD ANALYSIS; BLOOD CLOTTING; BLOOD DONOR; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; KIDNEY VEIN THROMBOSIS; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RENAL ARTERY THROMBOSIS; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; THROMBOPHILIA; UREMIA; VASCULAR ACCESS;

ANTIBODIES; ANTIBODIES, ANTICARDIOLIPIN; FACTOR VIII; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; RENAL DIALYSIS; RISK FACTORS; THROMBOSIS;

EID: 5444237050     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2004.06.004     Document Type: Conference Paper

References (25)

1. R.W. Steiner, C. Coggins, A.C.A. Carvalho Bleeding time in uremia A useful test to assess clinical bleeding Am J Hematol 7 1979 107
2. M. Livio, A. Benigni, G. Remuzzi Coagulation abnormalities in uremia Semin Nephrol 5 1985 82 90
3. G. Remuzzi Bleeding in renal failure Lancet 1 1988 1205
4. M. Noris, G. Remuzzi Uremic bleeding Closing the circle after 30 years of controversies? Blood 94 1999 2569 2574
5. N. Deguchi, T. Ohigashi, H Tazaki Haemodialysis and platelet activation Nephrol Dial Transplant 2 1991 40
6. J. Himmelfarb, D. Holbrook, E. McMonagle Increased reticulated platelets in dialysis patients Kidney Int 51 1997 834
7. N. Kazatchkine, Y. Sultan, J.P. Caen Bleeding in renal failure A possible cause BMJ 2 1976 612
8. N.D. Vaziri, E.C. Gonzales, J. Wang Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease Effect of hemodialysis Am J Kidney Dis 23 1994 828 835
9. S. De Marchi, E. Falleti, R. Giacomello Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients J Am Soc Nephrol 7 1996 1169 1177
10. G. Di Mimmo, J. Martinez, M. McKean Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis Am J Med 79 1985 552
11. N.G. De Santo, G. Capodicasa, N. Perna Haematoma of rectus abdominis associated with dialysis BMJ 3 1972 281 282
12. A. Segarra, P. Chacon, C. Martinez-Eyarre Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients Biochemical correlations and role as independent predictors of coronary artery stenosis J Am Soc Nephrol 12 2001 1255 1263
13. E. Baskin, O. Duman, N. Besbas Hypercoagulopathy in a hemodialysis patient Are elevations in factors VII and VIII effective? Nephron 83 1999 180
14. S. Adler, L. Szczech, A. Qureshi IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis Clin Nephrol 56 2001 428 434
15. R. Prakash, C.C. Miller 3rd, W.W. Suki Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis Am J Kidney Dis 26 1995 347 352
16. S.L. Chew, R.L. Lins, R. Daelemans Are antiphospholipid antibodies clinically relevant in dialysis patients Nephrol Dial Transplant 14 1992 1194 1198
17. Y. Ishii, S. Yano, H. Kanai Evaluation of blood coagulation-fibrinolysis system in patients receiving chronic hemodialysis Nephron 73 1996 407 412
18. E. Angles-Cano, M.C. Guillin Antiphospholipid antibodies and the coagulation cascade Clin Chem 47 2001 1008 1015
19. A. Yu, N. Egberg, S.H. Jacobson Haemostatic complications in haemodialysis patients Effect of type of vascular access and dialysis filter Scand J Clin Lab 63 2003 127 133
20. N.D. Vaziri, J. Toohey, P. Paule Coagulation abnormalities in patients with end-stage renal disease treated with hemodialysis Int J Artif Organs 7 1984 323 326
21. J.L. Vanherweghem, T. Yassine, M. Goldmann Subclavian vein thrombosis A frequent complication of subclavian vein cannulation for hemodialysis Clin Nephrol 26 1986 235 238
22. H.M. Kauffman Jr, G.A. Ekbom, M.B. Adams Hypercoagulability A cause of vascular access failure Proc Clin Dial Transplant Forum 9 1979 28 31
23. G. De Pergola, N. Pannacciulli Coagulation and fibrinolysis abnormalities in obesity J Endocrinol Invest 25 2002 899 904
24. M.A. Spittle, N.A. Hoenich, G.J. Handelman Oxidative stress and inflammation in hemodialysis patients Am J Kidney Dis 38 2001 1408 1413
25. J. Borwski, B. Naumnik, K. Pawlak Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients Associations with pre-dialysis blood pressure and the acute phase response Nephrol Dial Transplant 16 2001 1442 1447